These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3283759)

  • 1. Multiple cell markers and flow cytometry in invasive bladder cancer.
    Javadpour N
    Prog Clin Biol Res; 1988; 260():189-201. PubMed ID: 3283759
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
    Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of prognosis in superficial bladder cancer.
    Fradet Y
    Semin Urol; 1992 Feb; 10(1):28-38. PubMed ID: 1565901
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
    Srougi M; Alves VA; Gayotto LC; Arap S
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Updating of prognostic factors in bladder carcinoma].
    Bellmunt Molins J; Cordón-Cardó C
    Med Clin (Barc); 1991 Nov; 97(19):749-54. PubMed ID: 1686925
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer.
    Mahdy E; Yoshihiro S; Zech L; Wester K; Pan Y; Busch C; Döhner H; Kallioniemi O; Bergerheim U; Malmström PU
    Anticancer Res; 1999; 19(1A):7-12. PubMed ID: 10226518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS; Miller AW; Coon JS
    Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
    [No Abstract]   [Full Text] [Related]  

  • 10. [Flow cytometry in cancer of the bladder].
    Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
    Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical appraisal of tumor markers in bladder cancer.
    Fradet Y; Cordon-Cardo C
    Semin Urol; 1993 Aug; 11(3):145-53. PubMed ID: 8105526
    [No Abstract]   [Full Text] [Related]  

  • 13. [The current concept of tumor markers in oncological urology--cell surface markers].
    Ianev V; Kumanov Kh; Tsvetkov D; Ormanov I
    Khirurgiia (Sofiia); 1989; 42(4):14-7. PubMed ID: 2585974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometry in cancer diagnosis.
    O'Hara MF; Bedrossian CW; Johnson TS; Barlogie B
    Prog Clin Pathol; 1984; 9():135-53. PubMed ID: 6364220
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA flow cytometry: a predictor of a high-risk group in cervical cancer.
    Anton M; Nenutil R; Rejthar A; Kopecny J; Ptackova B; Zaloudik J
    Cancer Detect Prev; 1997; 21(3):242-6. PubMed ID: 9167041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the DD23 tumor-associated antigen for bladder cancer detection and recurrence monitoring. Marker Network for Bladder Cancer.
    Bonner RB; Liebert M; Hurst RE; Grossman HB; Bane BL; Hemstreet GP
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):971-8. PubMed ID: 8959319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometry in diagnosis and treatment of bladder tumor].
    Sun XJ; Song ZL; Wu DC
    Zhonghua Wai Ke Za Zhi; 1994 Mar; 32(3):178-80. PubMed ID: 7842912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors and markers used in urothelial carcinoma of the bladder].
    Billerey C; Vieillefond A
    Ann Pathol; 1999; 19(5 Suppl):S107-9. PubMed ID: 10599469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.